TSC22 domain family member 1 (TSC22D1)

TSC22 domain family member 1 (TSC22D1) is a leucine zipper-containing transcription factor, predominantly acting as a transcriptional repressor that is upregulated by transforming growth factor beta (TGF-β) and other signals[1][2][3]. It modulates the transcription of diverse genes, including C-type natriuretic peptide, and mediates key cellular processes such as growth inhibition, differentiation, and apoptosis—often functioning as a tumor suppressor[1][2][3]. In various cancers, TSC22D1 promotes cell cycle arrest and differentiation, and its loss is associated with increased malignancy. Functionally, it can form homodimers or heterodimers (notably with TSC22D4) through its leucine zipper domain, and it interacts with central signaling proteins such as Smad3/4, p53, and fortilin[1][2][3]. Beyond cancer, TSC22D1 has roles in metabolic disease, with genetic variants linked to diabetic nephropathy and recent research implicating it in the negative regulation of insulin secretion in pancreatic beta cells[4]. Multiple alternatively spliced isoforms exist, which may fine-tune context-dependent cellular and signaling responses[1][3]. No known therapeutic drugs directly target TSC22D1, but it remains an important molecule for cancer biology, metabolic regulation, and as a potential biomarker in some diseases[1][3][4].

Other names

TSC22 domain family protein 1KIAA1994TGFB1I4TSC22hucep-2HUCEP-2MGC17597Cerebral protein 2Regulatory protein TSC-22TGFB-stimulated clone 22 homologTransforming growth factor beta-1-induced transcript 4 proteinPtg-2transcriptional regulator TSC-22transforming growth factor beta-stimulated protein TSC-22